Stereotactic body radiotherapy in pancreatic adenocarcinoma.
de la Pinta C.
Hepatobiliary Pancreat Dis Int. 2024 Feb;23(1):14-19. doi: 10.1016/j.hbpd.2023.03.002. Epub 2023 Mar 16.
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview.
Matsuo Y.
Curr Oncol. 2023 Feb 18;30(2):2493-2500. doi: 10.3390/curroncol30020190.
Stereotactic body radiotherapy for spinal metastases: a review.
Guo L, Ke L, Zeng Z, Yuan C, Wu Z, Chen L, Lu L.
Med Oncol. 2022 May 23;39(5):103. doi: 10.1007/s12032-021-01613-8.
[Stereotactic body radiotherapy: Passing fad or revolution?].
Vallard A, Vial N, Jmour O, Rehailia-Blanchard A, Trone JC, Sotton S, Daguenet E, Guy JB, Magné N.
Bull Cancer. 2020 Feb;107(2):244-253. doi: 10.1016/j.bulcan.2019.09.011. Epub 2019 Dec 19.
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives.
Imano N.
Int J Clin Oncol. 2025 Aug;30(8):1505-1521. doi: 10.1007/s10147-025-02776-4. Epub 2025 May 17.
Stereotactic body radiotherapy for lung cancer: a review.
Nagata Y, Kimura T.
Jpn J Clin Oncol. 2025 Dec 3;55(12):1316-1325. doi: 10.1093/jjco/hyaf142.
Stereotactic body radiotherapy.
Kollar L, Rengan R.
Semin Oncol. 2014 Dec;41(6):776-89. doi: 10.1053/j.seminoncol.2014.09.022. Epub 2014 Oct 7.
Stereotactic Body Radiotherapy for Liver Metastases.
Goodman KA, Kavanagh BD.
Semin Radiat Oncol. 2017 Jul;27(3):240-246. doi: 10.1016/j.semradonc.2017.02.004. Epub 2017 Feb 20.
Postoperative stereotactic body radiotherapy for spinal metastases.
Alghamdi M, Tseng CL, Myrehaug S, Maralani P, Heyn C, Soliman H, Lee Y, Ruschin M, Da Costa L, Yang V, Campbell M, Sahgal A.
Chin Clin Oncol. 2017 Sep;6(Suppl 2):S18. doi: 10.21037/cco.2017.06.27.
Stereotactic body radiotherapy.
Dahele M, McLaren DB.
Clin Oncol (R Coll Radiol). 2015 May;27(5):249-50. doi: 10.1016/j.clon.2015.02.002. Epub 2015 Feb 24.
